211 related articles for article (PubMed ID: 7650418)
1. Autoantibodies in systemic sclerosis.
Vázquez-Abad D; Rothfield NF
Int Rev Immunol; 1995; 12(2-4):145-57. PubMed ID: 7650418
[TBL] [Abstract][Full Text] [Related]
2. Idiotypic analysis of human anti-topoisomerase I autoantibodies.
Hildebrandt S; Noell GS; Vazquez-Abad D; Earnshaw WC; Zanetti M; Rothfield NF
Autoimmunity; 1991; 10(1):41-8. PubMed ID: 1660312
[TBL] [Abstract][Full Text] [Related]
3. Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis.
Patterson KA; Roberts-Thomson PJ; Lester S; Tan JA; Hakendorf P; Rischmueller M; Zochling J; Sahhar J; Nash P; Roddy J; Hill C; Nikpour M; Stevens W; Proudman SM; Walker JG
Arthritis Rheumatol; 2015 Dec; 67(12):3234-44. PubMed ID: 26246178
[TBL] [Abstract][Full Text] [Related]
4. Clinical associations of anticentromere antibodies and antibodies to topoisomerase I. A study of 355 patients.
Weiner ES; Earnshaw WC; Senécal JL; Bordwell B; Johnson P; Rothfield NF
Arthritis Rheum; 1988 Mar; 31(3):378-85. PubMed ID: 2833902
[TBL] [Abstract][Full Text] [Related]
5. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
Hamaguchi Y
J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
[TBL] [Abstract][Full Text] [Related]
6. A case of systemic sclerosis with anticentromere, antitopoisomerase I, and anti-U1RNP antibodies.
Sato S; Ihn H; Soma Y; Shimozuma M; Shishiba T; Takehara K
J Rheumatol; 1993 Nov; 20(11):1961-3. PubMed ID: 8308786
[TBL] [Abstract][Full Text] [Related]
7. Clinical and serological associations with anti-RNA polymerase antibodies in systemic sclerosis.
Harvey GR; Butts S; Rands AL; Patel Y; McHugh NJ
Clin Exp Immunol; 1999 Aug; 117(2):395-402. PubMed ID: 10444276
[TBL] [Abstract][Full Text] [Related]
8. The concurrence of rheumatoid arthritis and limited systemic sclerosis: clinical and serologic characteristics of an overlap syndrome.
Zimmermann C; Steiner G; Skriner K; Hassfeld W; Petera P; Smolen JS
Arthritis Rheum; 1998 Nov; 41(11):1938-45. PubMed ID: 9811047
[TBL] [Abstract][Full Text] [Related]
9. Coexistence of antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis.
Dick T; Mierau R; Bartz-Bazzanella P; Alavi M; Stoyanova-Scholz M; Kindler J; Genth E
Ann Rheum Dis; 2002 Feb; 61(2):121-7. PubMed ID: 11796397
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic survey in systemic sclerosis: correlation of aneuploidy with the presence of anticentromere antibodies.
Jabs EW; Tuck-Muller CM; Anhalt GJ; Earnshaw W; Wise RA; Wigley F
Cytogenet Cell Genet; 1993; 63(3):169-75. PubMed ID: 8387418
[TBL] [Abstract][Full Text] [Related]
11. A cross-reactive idiotype in scleroderma.
Vázquez-Abad D; Tian L; Zanetti M; Rothfield NF
Clin Exp Immunol; 1997 Jun; 108(3):420-7. PubMed ID: 9182886
[TBL] [Abstract][Full Text] [Related]
12. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
13. Immunological characterization of heterochromatin protein p25beta autoantibodies and relationship with centromere autoantibodies and pulmonary fibrosis in systemic scleroderma.
Furuta K; Hildebrandt B; Matsuoka S; Kiyosawa K; Reimer G; Luderschmidt C; Chan EK; Tan EM
J Mol Med (Berl); 1998 Jan; 76(1):54-60. PubMed ID: 9462868
[TBL] [Abstract][Full Text] [Related]
14. The association of primary biliary cirrhosis and systemic sclerosis is not accounted for by cross reactivity between mitochondrial and centromere antigens.
Whyte J; Hough D; Maddison PJ; McHugh NJ
J Autoimmun; 1994 Jun; 7(3):413-24. PubMed ID: 7522457
[TBL] [Abstract][Full Text] [Related]
15. Anticentromere autoantibodies in patients without Raynaud's disease or systemic sclerosis.
Vázquez-Abad D; Grodzicky T; Senécal JL
Clin Immunol; 1999 Feb; 90(2):182-9. PubMed ID: 10080829
[TBL] [Abstract][Full Text] [Related]
16. Antikinetochore and antitopoisomerase I antibodies in systemic scleroderma: comparative study using immunoblotted recombinant antigens, immunofluorescence, and double immunodiffusion.
Jarzabek-Chorzelska M; Blaszczyk M; Kolacinska-Strasz Z; Chorzelski T; Jabłońska S; Maul GG
Arch Dermatol Res; 1990; 282(2):76-83. PubMed ID: 2162156
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of anticentromere antibodies and anti-topoisomerase I antibodies in Raynaud's disease. A prospective study.
Weiner ES; Hildebrandt S; Senécal JL; Daniels L; Noell S; Joyal F; Roussin A; Earnshaw W; Rothfield NF
Arthritis Rheum; 1991 Jan; 34(1):68-77. PubMed ID: 1845841
[TBL] [Abstract][Full Text] [Related]
18. Atypical autoantibodies in patients with primary Sjögren syndrome: clinical characteristics and follow-up of 82 cases.
Ramos-Casals M; Nardi N; Brito-Zerón P; Aguiló S; Gil V; Delgado G; Bové A; Font J
Semin Arthritis Rheum; 2006 Apr; 35(5):312-21. PubMed ID: 16616154
[TBL] [Abstract][Full Text] [Related]
19. Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies.
Krzyszczak ME; Li Y; Ross SJ; Ceribelli A; Chan EK; Bubb MR; Sobel ES; Reeves WH; Satoh M
Clin Rheumatol; 2011 Oct; 30(10):1333-9. PubMed ID: 21523365
[TBL] [Abstract][Full Text] [Related]
20. New centromere autoantigens identified in systemic sclerosis using centromere protein microarrays.
Song G; Hu C; Zhu H; Wang L; Zhang F; Li Y; Wu L
J Rheumatol; 2013 Apr; 40(4):461-8. PubMed ID: 23418382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]